scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0009-8981(98)00083-7 |
P698 | PubMed publication ID | 9721074 |
P2093 | author name string | H Alho | |
T Lehtimäki | |||
A Pasternack | |||
T Koivula | |||
T Solakivi | |||
V Rantalaiho | |||
O Wirta | |||
J S Leinonen | |||
P2860 | cites work | Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications | Q71457643 |
Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient? | Q72648151 | ||
Increased susceptibility to lipid oxidation of low-density lipoproteins and erythrocyte membranes from diabetic patients | Q72883070 | ||
Immune response to glycated and oxidized LDL in IDDM patients with and without renal disease | Q73459034 | ||
Vitamin E/lipid peroxide ratio and susceptibility of LDL to oxidative modification in non-insulin-dependent diabetes mellitus | Q73596770 | ||
The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis | Q36086849 | ||
Modification of lipoproteins in diabetes | Q41155220 | ||
Low density lipoprotein oxidation and its pathobiological significance | Q41566828 | ||
New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. | Q50919931 | ||
Impact of concentrations of glycated hemoglobin, alpha-tocopherol, copper, and manganese on oxidation of low-density lipoproteins in patients with type I diabetes, type II diabetes and control subjects. | Q50995646 | ||
Enhanced susceptibility of low-density lipoprotein to in vitro oxidation in type 1 and type 2 diabetic patients. | Q51046076 | ||
Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. | Q51579355 | ||
Plasma malondialdehyde in type 1 and type 2 diabetic patients. | Q51601881 | ||
The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed type 2 (non-insulin-dependent) diabetes. | Q51637132 | ||
The association between the total antioxidant potential of plasma and the presence of coronary heart disease and renal dysfunction in patients with NIDDM. | Q52229234 | ||
Total radical-trapping antioxidant parameter in NIDDM patients. | Q52275754 | ||
Measurement of glomerular filtration-rate in man using a 51Cr-edetic-acid complex. | Q54422024 | ||
Autoantibody against oxidised LDL and progression of carotid atherosclerosis | Q59704366 | ||
Relation of Lipid Peroxides to Macrovascular Disease in Type 2 Diabetes | Q65002306 | ||
Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man | Q67516427 | ||
Single vertical spin density gradient ultracentrifugation | Q69553503 | ||
Continuous monitoring of in vitro oxidation of human low density lipoprotein | Q69611707 | ||
Glycation accelerates the oxidation of low density lipoprotein by copper ions | Q70885663 | ||
Oxidation of low-density lipoprotein in NIDDM: its relationship to fatty acid composition | Q70953759 | ||
P433 | issue | 2 | |
P921 | main subject | heart disease | Q190805 |
coronary artery disease | Q844935 | ||
P304 | page(s) | 163-174 | |
P577 | publication date | 1998-07-01 | |
P1433 | published in | Clinica Chimica Acta | Q5133740 |
P1476 | title | Susceptibility of LDL to oxidation is not associated with the presence of coronary heart disease or renal dysfunction in NIDDM patients | |
P478 | volume | 275 |
Q45281586 | Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia. |
Q36922738 | Delta-6-desaturase gene polymorphism is associated with lipoprotein oxidation in vitro |
Q24810947 | HDL enhances oxidation of LDL in vitro in both men and women |
Q44855691 | Impact of long-term hormone replacement therapy on in vivo and in vitro markers of lipid oxidation |
Q34310277 | Pathophysiology of oxidative stress in diabetes mellitus |
Search more.